PUMA BIOTECHNOLOGY, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $8.2M | $-3.8M | $8.8M | $5.9M | $3.0M | $20.3M | $-4.5M | $-4.8M |
| Depreciation & Amortization | — | $2.6M | — | — | $2.8M | — | — | $2.9M |
| Depreciation | — | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K |
| Amortization | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M | $2.4M |
| Stock-Based Compensation | — | $1.9M | — | — | $2.0M | — | — | $2.4M |
| Net Cash from Operating Activities | $1.6M | $15.4M | $9.7M | $14.1M | $3.6M | $11.0M | $1.0M | $11.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $26.0K | $20.0K | $61.0K | $20.0K | $20.0K | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $2.5M | — | — | $1.5M | — | — | $-19.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-11.3M | — | — | $-11.3M | — | — | $0 |
| Net Change in Cash | — | $6.6M | — | — | $-6.2M | — | — | $-7.8M |
| Free Cash Flow | $1.6M | $15.4M | $9.7M | $14.1M | $3.6M | $11.0M | $1.0M | $11.2M |